[HTML][HTML] Pretreatment lymphopenia, poor performance status, and early courses of therapy are risk factors for severe bacterial infection in patients with multiple …
SY Hyun, SH Han, SJ Kim, JE Jang, Y Kim… - Journal of Korean …, 2016 - ncbi.nlm.nih.gov
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
Pretreatment lymphopenia, poor performance status, and early courses of therapy are risk factors for severe bacterial infection in patients with multiple myeloma …
SY Hyun, SH Han, SJ Kim, JE Jang… - Journal of Korean …, 2016 - yonsei.pure.elsevier.com
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomibbased regimens. A …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomibbased regimens. A …
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma …
SY Hyun, SH Han, SJ Kim, JE Jang, Y Kim, H Cho… - 2016 - ir.ymlib.yonsei.ac.kr
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma …
SY Hyun, SH Han, SJ Kim, JE Jang… - Journal of Korean …, 2016 - pubmed.ncbi.nlm.nih.gov
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma …
SY Hyun, SH Han, SJ Kim, JE Jang, Y Kim… - Journal of Korean …, 2016 - komci.org
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma …
SY Hyun, SH Han, SJ Kim, JE Jang, Y Kim… - Journal of Korean …, 2016 - europepmc.org
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
[HTML][HTML] Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple …
SY Hyun, SH Han, SJ Kim, JE Jang, Y Kim… - Journal of Korean …, 2016 - jkms.org
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
Pretreatment lymphopenia, poor performance status, and early courses of therapy are risk factors for severe bacterial infection in patients with multiple myeloma …
SY Hyun, SH Han, SJ Kim, JE Jang… - Journal of Korean …, 2016 - yonsei.elsevierpure.com
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomibbased regimens. A …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomibbased regimens. A …
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma …
SY Hyun, SH Han, SJ Kim, JE Jang, Y Kim… - Journal of Korean …, 2016 - jkms.kr
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
Pretreatment Lymphopenia, Poor Performance Status, and Early Courses of Therapy Are Risk Factors for Severe Bacterial Infection in Patients with Multiple Myeloma …
SY Hyun, SH Han, SJ Kim, JE Jang… - Journal of Korean …, 2016 - wprim.whocc.org.cn
The aim of this study was to identify the risk factors associated with severe bacterial infection
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …
(SBI) in multiple myeloma (MM) patients during treatment with bortezomib-based regimens …